PTHrP on MCF-7 breast cancer cells: a growth factor or an antimitogenic peptide? - Wikidata - awgldk - TriplyDB

PTHrP on MCF-7 breast cancer cells: a growth factor or an antimitogenic peptide?

PTHrP on MCF-7 breast cancer cells: a growth factor or an antimitogenic peptide?

http://www.wikidata.org/entity/Q43248830

about

PTHrP inhibits BMP-6 expression through the PKA signaling pathway in breast cancer cells.Antiproliferative and survival properties of PMA in MCF-7 breast cancer cell.

P2860

Q39713438-09181325-91F2-442F-9589-A21DBA13A622 Q40027479-2330DDA9-096E-4B05-B3A6-7723764B890E

P2860

PTHrP on MCF-7 breast cancer cells: a growth factor or an antimitogenic peptide?

http://www.wikidata.org/entity/Q43248830

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

PTHrP on MCF-7 breast cancer cells: a growth factor or an antimitogenic peptide?

@en

PTHrP on MCF-7 breast cancer cells: a growth factor or an antimitogenic peptide?

@nl

type

label

PTHrP on MCF-7 breast cancer cells: a growth factor or an antimitogenic peptide?

@en

PTHrP on MCF-7 breast cancer cells: a growth factor or an antimitogenic peptide?

@nl

prefLabel

PTHrP on MCF-7 breast cancer cells: a growth factor or an antimitogenic peptide?

@en

PTHrP on MCF-7 breast cancer cells: a growth factor or an antimitogenic peptide?

@nl

P1433

Q43248830-F9D191C1-682C-4497-B107-0736CB67044C

P1476

Q43248830-D33D3997-25F2-4A87-AFDF-378277F4FF21

P2093

Q43248830-915CA6F2-9664-4AE3-83D9-FEA8BA2D3760

P2860

Q43248830-01E6EABE-8883-4FD4-85C8-8ADDB1DD1AAA

Q43248830-296D27C5-FBB1-475D-9B34-E6DED4B37F13

Q43248830-3355A60D-8F14-4BB2-AEA8-3266CBC0F748

Q43248830-3E4A9E40-A508-44A9-90D9-BEC8E145F7A3

Q43248830-4BF89586-BA4A-484F-8E48-37B0B1B74EBD

Q43248830-62EC5E89-6E5A-48A8-B33B-99642B2EF6C6

Q43248830-8B18569A-B947-4217-A999-0DF4CF5BAD46

Q43248830-B10E6343-73A0-4F23-98E1-A8180CFA1CDF

Q43248830-B3700E23-73A8-4485-B079-1CA42FB6FC42

Q43248830-B7F69FD3-C551-4DD8-8D27-A070140D3EB3

P2888

Q43248830-3D51A791-D7DD-485D-A077-F9BD3AB597BD

P304

Q43248830-2FD07B96-2913-4762-A15B-CD1AE71E3022

P31

Q43248830-2E9BAF46-C77A-4F4D-84FC-941307B0088F

P356

Q43248830-A270C2F2-7171-47C5-AC39-769EA26F6496

P407

Q43248830-78BC5E73-1A6E-486F-BA4D-CB35A228AA2E

P433

Q43248830-6FF0F8DA-B74F-434F-A91F-4F9FCA26236F

P478

Q43248830-244B9A37-9254-4A34-BFBD-795E084DA222

P50

Q43248830-8422BD78-9142-494D-80C2-4FA7A4D45FDE

P577

Q43248830-97ECE060-6C2B-4FDC-A141-AC5B776515C7

P5875

Q43248830-062482B9-2625-4DBE-BD4D-B8A196124736

P698

Q43248830-B85572CD-85A8-4FB4-B324-D7F1D09EE7C3

P932

Q43248830-E57DA83F-EAB9-4F82-B3C0-82ED6E7B7140

P356

P1433

British Journal of Cancer

P1476

PTHrP on MCF-7 breast cancer cells: a growth factor or an antimitogenic peptide?

@en

P2093

V Fortino

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of Q227L-galphas in MCF-7 human breast cancer cells inhibits tumorigenesis

Enhanced growth of MCF-7 breast cancer cells overexpressing parathyroid hormone-related peptide

Opposing mitogenic and anti-mitogenic actions of parathyroid hormone-related protein in vascular smooth muscle cells: a critical role for nuclear targeting.

Integration of signals from receptor tyrosine kinases and g protein-coupled receptors.

Parathyroid hormone (PTH)/PTH-related protein (PTHrP) receptor expression and mitogenic responses in human breast cancer cell lines.

The parathyroid hormone-related protein receptor is expressed in breast cancer bone metastases and promotes autocrine proliferation in breast carcinoma cells

New signaling pathway for parathyroid hormone and cyclic AMP action on extracellular-regulated kinase and cell proliferation in bone cells. Checkpoint of modulation by cyclic AMP.

Intracrine PTHrP protects against serum starvation-induced apoptosis and regulates the cell cycle in MCF-7 breast cancer cells.

Role of the Raf signal transduction cascade in the in vitro resistance to the anticancer drug doxorubicin.

ERKs are the point of divergence of PKA and PKC activation by PTHrP in human skin fibroblasts.

P2888

P304

1293-4; author reply 1295

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6601689

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P50

Emanuela Maioli

P577

2004-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8673997

http://www.w3.org/2001/XMLSchema#string

P698

15026815

http://www.w3.org/2001/XMLSchema#string

P932

2409645

http://www.w3.org/2001/XMLSchema#string